PGNY NASDAQ
Progyny, Inc.
1W: +8.0%
1M: +37.2%
3M: +17.7%
YTD: -4.1%
1Y: +12.9%
3Y: -31.3%
5Y: -51.1%
$24.88
+0.19 (+0.77%)
Weekly Expected Move ±12.8%
$17
$20
$23
$26
$29
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.45
Bullish
1 bullish
1 neutral
0 bearish
Articles (7d)
2
Daily Sentiment (7 Days)
Articles (54)
Progyny and Standex International have been highlighted as Zacks Bull and Bear of the Day
Bull of the Day: Progyny (PGNY)
3 Highly Ranked Medical Stocks to Buy Now: DVA, GMED, PGNY
AUNA Q1 Earnings Preview: How Should You Play the Stock Now?
Trump administration proposes easier employer access to IVF benefits
Progyny (PGNY) Q1 2026 Earnings Call Transcript
12 Health Care Stocks Moving In Friday's Pre-Market Session
Progyny anticipates 2026 revenue of $1.365B-$1.405B while raising adjusted EBITDA to $232M-$244M
Progyny, Inc. Q1 2026 Earnings Call Summary
Progyny (PGNY) Q1 Earnings and Revenues Beat Estimates
12 Health Care Stocks Moving In Thursday's After-Market Session
Progyny Non-GAAP EPS of $0.50 beats by $0.06, revenue of $328.5M beats by $1.99M
Progyny, Inc. Announces First Quarter 2026 Results
Here are the major earnings after the close Thursday
Should Value Investors Buy Progyny (PGNY) Stock?
Progyny (PGNY) Upgraded to Buy: Here's Why
PGNY or ALHC: Which Is the Better Value Stock Right Now?
Progyny, Inc. (NASDAQ:PGNY) Receives Consensus Rating of “Moderate Buy” from Analysts
Progyny, Inc. Announces Details for Its First Quarter 2026 Results Report
Managed care stocks jump after UNH's Q1 report: Here are the 9 best Quant rated names
Progyny Expands Access to Fertility and Women’s Health with Industry’s First Fully Insured Supplemental Plan
Quant check on insurer stocks as Medicare Advantage rate boost drives gains
Progyny Commemorates 10 Years of Redefining Women's Health and Family Building Care
Progyny, Inc. (NASDAQ:PGNY) Given Average Recommendation of “Moderate Buy” by Analysts
Progyny, Inc. Investigated by the Portnoy Law Firm
Small-cap high-quality stocks amid rising volatility
Progyny, Inc. $PGNY Shares Purchased by Algert Global LLC
ArrowMark Colorado Holdings LLC Raises Stock Position in Progyny, Inc. $PGNY
Progyny, Inc. Executives to Participate in Upcoming Investor Conferences
Progyny, Inc. (NASDAQ:PGNY) Given Average Rating of “Moderate Buy” by Brokerages
Short Interest in Progyny, Inc. (NASDAQ:PGNY) Increases By 41.0%
Progyny (NASDAQ:PGNY) Sets New 1-Year Low – Here’s What Happened
Flutter Entertainment Posts Downbeat Q4 Results, Joins Zscaler, Elastic And Other Big Stocks Moving Lower In Friday's Pre-Market Session (CORRECTED)
Progyny outlines 2026 revenue guidance of $1.355B–$1.405B as company launches new Select product for small employers
Progyny Non-GAAP EPS of $0.48 beats by $0.08, revenue of $318.4M beats by $4.14M
Progyny, Inc. (PGNY) Q4 2025 Earnings Call Transcript
Progyny (PGNY) Q4 Earnings and Revenues Surpass Estimates
Compared to Estimates, Progyny (PGNY) Q4 Earnings: A Look at Key Metrics
Progyny, Inc. Announces Fourth Quarter 2025 Results
Seeking Clues to Progyny (PGNY) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report
105,000 Shares in Progyny, Inc. $PGNY Acquired by Hussman Strategic Advisors Inc.
Progyny, Inc. (PGNY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference
Progyny, Inc. (PGNY) Soars to 52-Week High, Time to Cash Out?
Pacer Advisors Inc. Has $8.29 Million Stock Holdings in Progyny, Inc. $PGNY
Zicix (OTCMKTS:ZICXD) vs. Progyny (NASDAQ:PGNY) Head-To-Head Survey
Progyny, Inc. (PGNY) Hits Fresh High: Is There Still Room to Run?
Progyny (PGNY) Upgraded to Buy: Here's What You Should Know
Edgestream Partners L.P. Boosts Stake in Progyny, Inc. $PGNY
CEO Peter Anevski Buys $1.9 Million of Progyny Stock: Should Investors Buy Too?
Is Progyny (PGNY) a Solid Growth Stock? 3 Reasons to Think "Yes"
New Men's Health Research from Progyny Challenges Conventional Beliefs about Fertility Knowledge and Action
Progyny: Growth Has Returned (Rating Upgrade)